B-cell receptor

Results: 110



#Item
61T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Brentjens/Sadelain Memorial Sloan Kettering Cancer Center

T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Brentjens/Sadelain Memorial Sloan Kettering Cancer Center

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:15:08
62T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D.

T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D.

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:16:28
63Session I Update on Current Approaches and Trials MDACC EXPERIENCE Laurence J.N. Cooper, M.D., Ph.D. MD Anderson Cancer Center

Session I Update on Current Approaches and Trials MDACC EXPERIENCE Laurence J.N. Cooper, M.D., Ph.D. MD Anderson Cancer Center

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:15:14
64High-throughput electronic literature libraries (e-libraries) to support development of toxicity prediction models and adverse outcome pathways (AOPs) Nancy C. Baker1, Thomas B. Knudsen2, Kevin M. Crofton2 1Lockheed Mar

High-throughput electronic literature libraries (e-libraries) to support development of toxicity prediction models and adverse outcome pathways (AOPs) Nancy C. Baker1, Thomas B. Knudsen2, Kevin M. Crofton2 1Lockheed Mar

Add to Reading List

Source URL: epa.gov

Language: English - Date: 2013-04-10 16:29:15
65National Institutes of Health (NIH) Safety Symposium Gene-Modified T cells: Challenges in Clinical Trial Design June 15, 2010

National Institutes of Health (NIH) Safety Symposium Gene-Modified T cells: Challenges in Clinical Trial Design June 15, 2010

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-08 13:16:10
66Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:35:21
67T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Brentjens/Sadelain Memorial Sloan Kettering Cancer Center

T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Brentjens/Sadelain Memorial Sloan Kettering Cancer Center

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:30:59
68Assay Development for the Determination of Phosphorylation Stoichiometry: Analysis of Breast Cancer Signaling Pathways Dominik Domanski, Michael A. Kuzyk, Leanne B. Ohlund, Tyra J. Cross and Christoph H. Borchers PPQ-MRM

Assay Development for the Determination of Phosphorylation Stoichiometry: Analysis of Breast Cancer Signaling Pathways Dominik Domanski, Michael A. Kuzyk, Leanne B. Ohlund, Tyra J. Cross and Christoph H. Borchers PPQ-MRM

Add to Reading List

Source URL: www.proteincentre.com

Language: English - Date: 2009-06-15 14:40:51
69Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:16:02
70T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D.

T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D.

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:37:02